Vaccination for App is even useful when mortality is low
Italian field studies show that vaccination against Actinobacillus pleuropneumoniae (App) is useful even when the mortality due to App is low. Vaccination leads to increased profitability by improving several production parameters.
To view this article in full click on the pdf link below.
